NEW YORK, Jan. 28 (GenomeWeb News) - Celera Diagnostics reported increased revenues and slightly smaller losses for the fiscal year 2004 second quarter today, along with decreased R&D spending.
For the quarter ended Dec. 31, 2003, Celera Diagnostics, a joint venture of Applied
Biosystems and Celera Genomics, both units of Applera, reported revenues of $11 million, compared to $7.8 million for the same period a year ago.
The company's net loss for the quarter amounted to $9.3 million, compared to $9.9 million in the prior year quarter.
Celera Diagnostics spent $10.6 million for R&D and engineering during the quarter, compared to $12.6 million the year before.